Researchers found that the Alzheimer’s patients had higher amounts of the FASN protein, they also showed that CMS121 lowered levels of a lipid-producing molecule called fatty acid synthetase (FASN), which, in turn, lowered levels of lipid peroxidation.
Read the Full Article from TechnologyNetworks